PSGR and PCA3 as biomarkers for the detection of prostate cancer in urine

Abstract

A multiplexed model including PSGR and PCA3 improves the specificity for the detection of PCa, especially in the area of high sensitivity. This could be clinically useful for determining which patients should undergo biopsy.